Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Accounting Policies, by Policy (Policies)
Notes Tables
Notes Details

SHARE CAPITAL

SHARE CAPITAL	3 Months Ended
Mar. 31, 2022
Share Capital [Abstract]
SHARE CAPITAL	5.SHARE CAPITAL Authorized: Unlimited number of no par value common shares. 111,202,690 common shares issued and outstanding as of March 31, 2022 (111,202,690 as of December 31, 2021)

SHARE CAPITAL

3 Months Ended

Mar. 31, 2022

Share Capital [Abstract]

SHARE CAPITAL

5.SHARE CAPITAL

Authorized: Unlimited number of no par value common shares. 111,202,690 common shares issued and outstanding as of March 31, 2022 (111,202,690 as of December 31, 2021)